Amphotericin B Injectable, Liposomal
Product Images NDC 62756-233

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amphotericin B (NDC 62756-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-ampho-lipo-structure (Spl Ampho Lipo Structure)

Cross-section illustration of a liposome showing amphotericin B molecules embedded within the phospholipid bilayer. The diagram highlights the structure of a liposomal delivery system for injectable amphotericin B.*

FDA Label Image

Spl-amphotercin-structure (Spl Amphotercin Structure)

Chemical structure of Amphotericin B, showing its molecular configuration with multiple hydroxyl groups, a macrolide ring, and sugar moiety as part of the compound's detailed formula.*

FDA Label Image

Spl-carton-1s (Spl Carton 1s)

Packaging label for Amphotericin B Liposome for Injection 50 mg/vial, an intravenous injectable liposomal drug. The label includes dosage, storage instructions, and a warning that this product is not interchangeable on a mg per mg basis with other Amphotericin B products. It is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Medicare Limited in India. The label lists vial contents and preservatives, and displays the NDC 62756-233-01 with a barcode.*

FDA Label Image

Spl-figure1 (Spl Figure1)

A line graph depicting mean change in creatinine levels (mg/dL) over 4 weeks on study for two Amphotericin B treatment dosages. The graph compares Amphotericin B Liposome for Injection 3 mg/kg/day and Amphotericin B 0.6 mg/kg/day, showing creatinine changes on the vertical axis and weeks on the horizontal axis, with patient numbers indicated for each time point.*

FDA Label Image

Spl-figure2 (Spl Figure2)

A line graph showing mean creatinine concentration (mg/dL) over the course of 40 days of test. It compares two groups: patients whose pretreatment value was greater than 1.7 mg/dL and all episodes. Data points include sample sizes indicated in parentheses.*

FDA Label Image

Spl-label (Spl Label)

Label for Amphotericin B Liposome for Injection 50 mg/vial, an intravenous injectable liposomal drug. The label lists active ingredients, dosage form, single-dose vial packaging, and storage instructions. Distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Medicare Limited in India. Includes NDC 62756-233-01 with lot and expiration date placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.